Losada Isabel, Cuervas-Mons Valentín, Millán Isabel, Dámaso Diego
Servicio de Microbiología. Complexo Hospitalario Juan Canalejo de A Coruña. España.
Enferm Infecc Microbiol Clin. 2002 Nov;20(9):422-30. doi: 10.1016/s0213-005x(02)72837-1.
To conduct a descriptive study with an analysis of risk factors for early infection in liver transplant patients, and to determine the resistance of the bacteria involved.
The study included 149 liver transplant recipients. All cases of infection occurring 0-90 days after transplantation were considered early infection. Pre-, intra- and postoperative variables were analyzed, and isolated microorganisms were studied. Selective bowel decontamination with quinolones, and perioperative and antifungal prophylaxis were carried out in all patients.
The incidence of infection was 73.1%: bacterial (49.7%), viral (35.5%), fungal (10.1%) and mixed (4.5%). In the first postoperative month the most frequent infections were bacterial and in the second and third months, viral (p = 0.001). Multivariate analysis of risk factors identified the following: days of parenteral nutrition, duration of surgery > 5 hours, rejection and CMV seronegative status. Among 1278 cultures, the following microorganisms were isolated: 77.9% gram-positive cocci (GP) and 19% aerobic gram-negative bacilli (GNB). Sensitivity of Staphylococcus to vancomycin was 99.6-100% and to teicoplanin 97.9-100%. VAN resistance was observed in 1.2% of E. faecalis and 4.5% of E. faecium. Among S. aureus strains, 68.7% were MRSA. The resistance rate of GNB to quinolones was 38.8%.
Incidence of infection was higher the first 30 days after transplantation, with bacterial infection predominating. Duration of surgery > 5 hours was the most important risk factor for acquiring bacterial infection. GP were the most frequently isolated bacteria. Empirical treatment of early bacterial infection should include vancomycin or teicoplanin. Selective bowel decontamination resulted in a low incidence of GNB infections, among which there was 38.8% resistance to quinolones.
进行一项描述性研究,分析肝移植患者早期感染的危险因素,并确定所涉及细菌的耐药性。
该研究纳入了149例肝移植受者。所有在移植后0至90天内发生的感染病例均被视为早期感染。分析术前、术中和术后变量,并对分离出的微生物进行研究。所有患者均进行了喹诺酮类药物的选择性肠道去污以及围手术期抗真菌预防。
感染发生率为73.1%:细菌感染(49.7%)、病毒感染(35.5%)、真菌感染(10.1%)和混合感染(4.5%)。术后第一个月最常见的感染是细菌感染,而在第二和第三个月则是病毒感染(p = 0.001)。危险因素的多因素分析确定了以下因素:肠外营养天数、手术时间>5小时、排斥反应和巨细胞病毒血清阴性状态。在1278份培养物中,分离出以下微生物:77.9%革兰氏阳性球菌(GP)和19%需氧革兰氏阴性杆菌(GNB)。葡萄球菌对万古霉素的敏感性为99.6 - 100%,对替考拉宁的敏感性为97.9 - 100%。在1.2%的粪肠球菌和4.5%的屎肠球菌中观察到万古霉素耐药。在金黄色葡萄球菌菌株中,68.7%为耐甲氧西林金黄色葡萄球菌。GNB对喹诺酮类药物的耐药率为38.8%。
移植后前30天感染发生率较高,以细菌感染为主。手术时间>5小时是获得细菌感染的最重要危险因素。GP是最常分离出的细菌。早期细菌感染的经验性治疗应包括万古霉素或替考拉宁。选择性肠道去污导致GNB感染发生率较低,其中对喹诺酮类药物的耐药率为38.8%。